Optimisation of an immunohistochemistry method for the determination of androgen receptor expression levels in circulating tumour cells

BACKGROUND: AZD3514 inhibits and down regulates the androgen receptor (AR) and has undergone clinical trials in prostate cancer. To provide proof-of-mechanism (POM) in patients, an immunohistochemistry (IHC) method for determination of AR in circulating tumour cells (CTC) was developed and validated...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cummings, Jeffrey, Sloane, Robert, Morris, Karen, Zhou, Cong, Lancashire, Matt, Moore, David, Elliot, Tony, Clarke, Noel, Dive, Caroline
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Technical Advance
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3977890/
https://ncbi.nlm.nih.gov/pubmed/24674711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-226
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados